糖尿病治療薬のグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Diabetes Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16128 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

糖尿病治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の糖尿病治療薬の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の糖尿病治療薬の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 糖尿病治療薬市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・インスリン、DPP-4、GLP-1、SGLT-2 用途別セグメントは次のように区分されます。 ・1型糖尿病、2型糖尿病 世界の糖尿病治療薬市場の主要な市場プレーヤーは以下のとおりです。 ・Sanofi、AstraZeneca、Bayer、Biocon、Boehringer Ingelheim、Dongbao Pharmaceutical、Eli Lilly、Ganlee、Ginwa、Guangzhou Baiyun Mountain、Hisun Pharmacy、Hua Dong、Huadong Medicine、Jumpcan Pharmacy、KELUN、Merck & Co.、MSD、North China Pharmaceutical Group Corporation、Novartis、Novo Nordisk、Sanofi、SHIJIAZHUANG YILING PHARMACEUTICAL、Takeda、Taloph、Tianan Pharmaceutical、Tonghua DongBao、Wanbang Biopharmaceuticals 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、糖尿病治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な糖尿病治療薬メーカーの企業概要、2019年～2021年までの糖尿病治療薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な糖尿病治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別糖尿病治療薬の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの糖尿病治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での糖尿病治療薬市場予測を収録しています。 ・第12、13、14章では、糖尿病治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Sanofi、AstraZeneca、Bayer、Biocon、Boehringer Ingelheim、Dongbao Pharmaceutical、Eli Lilly、Ganlee、Ginwa、Guangzhou Baiyun Mountain、Hisun Pharmacy、Hua Dong、Huadong Medicine、Jumpcan Pharmacy、KELUN、Merck & Co.、MSD、North China Pharmaceutical Group Corporation、Novartis、Novo Nordisk、Sanofi、SHIJIAZHUANG YILING PHARMACEUTICAL、Takeda、Taloph、Tianan Pharmaceutical、Tonghua DongBao、Wanbang Biopharmaceuticals ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：インスリン、DPP-4、GLP-1、SGLT-2 ・用途別分析2016年-2026年：1型糖尿病、2型糖尿病 ・糖尿病治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・糖尿病治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・糖尿病治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・糖尿病治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・糖尿病治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Diabetes Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Diabetes Drugs size is estimated to be XX million in 2021 from USD 52510 million in 2020, with a change of XX% between 2020 and 2021. The global Diabetes Drugs market size is expected to grow at a CAGR of 5.3% for the next five years.

Market segmentation
Diabetes Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Insulin
DPP-4
GLP-1
SGLT-2

Market segment by Application can be divided into
Type 1 Diabetes
Type 2 Diabetes

The key market players for global Diabetes Drugs market are listed below:
Sanofi
AstraZeneca
Bayer
Biocon
Boehringer Ingelheim
Dongbao Pharmaceutical
Eli Lilly
Ganlee
Ginwa
Guangzhou Baiyun Mountain
Hisun Pharmacy
Hua Dong
Huadong Medicine
Jumpcan Pharmacy
KELUN
Merck & Co.
MSD
North China Pharmaceutical Group Corporation
Novartis
Novo Nordisk
Sanofi
SHIJIAZHUANG YILING PHARMACEUTICAL
Takeda
Taloph
Tianan Pharmaceutical
Tonghua DongBao
Wanbang Biopharmaceuticals

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Diabetes Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Diabetes Drugs, with price, sales, revenue and global market share of Diabetes Drugs from 2019 to 2021.
Chapter 3, the Diabetes Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diabetes Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Diabetes Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Diabetes Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Diabetes Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Diabetes Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Insulin
1.2.3 DPP-4
1.2.4 GLP-1
1.2.5 SGLT-2
1.3 Market Analysis by Application
1.3.1 Overview: Global Diabetes Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Global Diabetes Drugs Market Size & Forecast
1.4.1 Global Diabetes Drugs Sales in Value (2016-2026))
1.4.2 Global Diabetes Drugs Sales in Volume (2016-2026)
1.4.3 Global Diabetes Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Diabetes Drugs Production Capacity Analysis
1.5.1 Global Diabetes Drugs Total Production Capacity (2016-2026)
1.5.2 Global Diabetes Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Diabetes Drugs Market Drivers
1.6.2 Diabetes Drugs Market Restraints
1.6.3 Diabetes Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Diabetes Drugs Product and Services
2.1.4 Sanofi Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Diabetes Drugs Product and Services
2.2.4 AstraZeneca Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Diabetes Drugs Product and Services
2.3.4 Bayer Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Biocon
2.4.1 Biocon Details
2.4.2 Biocon Major Business
2.4.3 Biocon Diabetes Drugs Product and Services
2.4.4 Biocon Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Diabetes Drugs Product and Services
2.5.4 Boehringer Ingelheim Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Dongbao Pharmaceutical
2.6.1 Dongbao Pharmaceutical Details
2.6.2 Dongbao Pharmaceutical Major Business
2.6.3 Dongbao Pharmaceutical Diabetes Drugs Product and Services
2.6.4 Dongbao Pharmaceutical Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly Diabetes Drugs Product and Services
2.7.4 Eli Lilly Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Ganlee
2.8.1 Ganlee Details
2.8.2 Ganlee Major Business
2.8.3 Ganlee Diabetes Drugs Product and Services
2.8.4 Ganlee Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Ginwa
2.9.1 Ginwa Details
2.9.2 Ginwa Major Business
2.9.3 Ginwa Diabetes Drugs Product and Services
2.9.4 Ginwa Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Guangzhou Baiyun Mountain
2.10.1 Guangzhou Baiyun Mountain Details
2.10.2 Guangzhou Baiyun Mountain Major Business
2.10.3 Guangzhou Baiyun Mountain Diabetes Drugs Product and Services
2.10.4 Guangzhou Baiyun Mountain Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Hisun Pharmacy
2.11.1 Hisun Pharmacy Details
2.11.2 Hisun Pharmacy Major Business
2.11.3 Hisun Pharmacy Diabetes Drugs Product and Services
2.11.4 Hisun Pharmacy Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Hua Dong
2.12.1 Hua Dong Details
2.12.2 Hua Dong Major Business
2.12.3 Hua Dong Diabetes Drugs Product and Services
2.12.4 Hua Dong Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Huadong Medicine
2.13.1 Huadong Medicine Details
2.13.2 Huadong Medicine Major Business
2.13.3 Huadong Medicine Diabetes Drugs Product and Services
2.13.4 Huadong Medicine Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Jumpcan Pharmacy
2.14.1 Jumpcan Pharmacy Details
2.14.2 Jumpcan Pharmacy Major Business
2.14.3 Jumpcan Pharmacy Diabetes Drugs Product and Services
2.14.4 Jumpcan Pharmacy Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 KELUN
2.15.1 KELUN Details
2.15.2 KELUN Major Business
2.15.3 KELUN Diabetes Drugs Product and Services
2.15.4 KELUN Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Merck & Co.
2.16.1 Merck & Co. Details
2.16.2 Merck & Co. Major Business
2.16.3 Merck & Co. Diabetes Drugs Product and Services
2.16.4 Merck & Co. Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 MSD
2.17.1 MSD Details
2.17.2 MSD Major Business
2.17.3 MSD Diabetes Drugs Product and Services
2.17.4 MSD Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 North China Pharmaceutical Group Corporation
2.18.1 North China Pharmaceutical Group Corporation Details
2.18.2 North China Pharmaceutical Group Corporation Major Business
2.18.3 North China Pharmaceutical Group Corporation Diabetes Drugs Product and Services
2.18.4 North China Pharmaceutical Group Corporation Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Novartis
2.19.1 Novartis Details
2.19.2 Novartis Major Business
2.19.3 Novartis Diabetes Drugs Product and Services
2.19.4 Novartis Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Novo Nordisk
2.20.1 Novo Nordisk Details
2.20.2 Novo Nordisk Major Business
2.20.3 Novo Nordisk Diabetes Drugs Product and Services
2.20.4 Novo Nordisk Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 Sanofi
2.21.1 Sanofi Details
2.21.2 Sanofi Major Business
2.21.3 Sanofi Diabetes Drugs Product and Services
2.21.4 Sanofi Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.22 SHIJIAZHUANG YILING PHARMACEUTICAL
2.22.1 SHIJIAZHUANG YILING PHARMACEUTICAL Details
2.22.2 SHIJIAZHUANG YILING PHARMACEUTICAL Major Business
2.22.3 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Product and Services
2.22.4 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.23 Takeda
2.23.1 Takeda Details
2.23.2 Takeda Major Business
2.23.3 Takeda Diabetes Drugs Product and Services
2.23.4 Takeda Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.24 Taloph
2.24.1 Taloph Details
2.24.2 Taloph Major Business
2.24.3 Taloph Diabetes Drugs Product and Services
2.24.4 Taloph Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.25 Tianan Pharmaceutical
2.25.1 Tianan Pharmaceutical Details
2.25.2 Tianan Pharmaceutical Major Business
2.25.3 Tianan Pharmaceutical Diabetes Drugs Product and Services
2.25.4 Tianan Pharmaceutical Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.26 Tonghua DongBao
2.26.1 Tonghua DongBao Details
2.26.2 Tonghua DongBao Major Business
2.26.3 Tonghua DongBao Diabetes Drugs Product and Services
2.26.4 Tonghua DongBao Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.27 Wanbang Biopharmaceuticals
2.27.1 Wanbang Biopharmaceuticals Details
2.27.2 Wanbang Biopharmaceuticals Major Business
2.27.3 Wanbang Biopharmaceuticals Diabetes Drugs Product and Services
2.27.4 Wanbang Biopharmaceuticals Diabetes Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Diabetes Drugs Sales by Manufacturer
3.1 Global Diabetes Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Diabetes Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Diabetes Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Diabetes Drugs Manufacturer Market Share
3.4.2 Top 6 Diabetes Drugs Manufacturer Market Share
3.5 Global Diabetes Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Diabetes Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Diabetes Drugs Market Size by Region
4.1.1 Global Diabetes Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Diabetes Drugs Revenue by Region (2016-2026)
4.2 North America Diabetes Drugs Revenue (2016-2026)
4.3 Europe Diabetes Drugs Revenue (2016-2026)
4.4 Asia-Pacific Diabetes Drugs Revenue (2016-2026)
4.5 South America Diabetes Drugs Revenue (2016-2026)
4.6 Middle East and Africa Diabetes Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Diabetes Drugs Sales in Volume by Type (2016-2026)
5.2 Global Diabetes Drugs Revenue by Type (2016-2026)
5.3 Global Diabetes Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Diabetes Drugs Sales in Volume by Application (2016-2026)
6.2 Global Diabetes Drugs Revenue by Application (2016-2026)
6.3 Global Diabetes Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Diabetes Drugs Sales by Type (2016-2026)
7.2 North America Diabetes Drugs Sales by Application (2016-2026)
7.3 North America Diabetes Drugs Market Size by Country
7.3.1 North America Diabetes Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Diabetes Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Diabetes Drugs Sales by Type (2016-2026)
8.2 Europe Diabetes Drugs Sales by Application (2016-2026)
8.3 Europe Diabetes Drugs Market Size by Country
8.3.1 Europe Diabetes Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Diabetes Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Diabetes Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Diabetes Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Diabetes Drugs Market Size by Region
9.3.1 Asia-Pacific Diabetes Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Diabetes Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Diabetes Drugs Sales by Type (2016-2026)
10.2 South America Diabetes Drugs Sales by Application (2016-2026)
10.3 South America Diabetes Drugs Market Size by Country
10.3.1 South America Diabetes Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Diabetes Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Diabetes Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Diabetes Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Diabetes Drugs Market Size by Country
11.3.1 Middle East & Africa Diabetes Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Diabetes Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Diabetes Drugs Typical Distributors
12.3 Diabetes Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Diabetes Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Diabetes Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Diabetes Drugs Product and Services
Table 6. Sanofi Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca Diabetes Drugs Product and Services
Table 10. AstraZeneca Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bayer Basic Information, Manufacturing Base and Competitors
Table 12. Bayer Major Business
Table 13. Bayer Diabetes Drugs Product and Services
Table 14. Bayer Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Biocon Basic Information, Manufacturing Base and Competitors
Table 16. Biocon Major Business
Table 17. Biocon Diabetes Drugs Product and Services
Table 18. Biocon Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Ingelheim Major Business
Table 21. Boehringer Ingelheim Diabetes Drugs Product and Services
Table 22. Boehringer Ingelheim Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Dongbao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Dongbao Pharmaceutical Major Business
Table 25. Dongbao Pharmaceutical Diabetes Drugs Product and Services
Table 26. Dongbao Pharmaceutical Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 28. Eli Lilly Major Business
Table 29. Eli Lilly Diabetes Drugs Product and Services
Table 30. Eli Lilly Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Ganlee Basic Information, Manufacturing Base and Competitors
Table 32. Ganlee Major Business
Table 33. Ganlee Diabetes Drugs Product and Services
Table 34. Ganlee Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Ginwa Basic Information, Manufacturing Base and Competitors
Table 36. Ginwa Major Business
Table 37. Ginwa Diabetes Drugs Product and Services
Table 38. Ginwa Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Guangzhou Baiyun Mountain Basic Information, Manufacturing Base and Competitors
Table 40. Guangzhou Baiyun Mountain Major Business
Table 41. Guangzhou Baiyun Mountain Diabetes Drugs Product and Services
Table 42. Guangzhou Baiyun Mountain Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Hisun Pharmacy Basic Information, Manufacturing Base and Competitors
Table 44. Hisun Pharmacy Major Business
Table 45. Hisun Pharmacy Diabetes Drugs Product and Services
Table 46. Hisun Pharmacy Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Hua Dong Basic Information, Manufacturing Base and Competitors
Table 48. Hua Dong Major Business
Table 49. Hua Dong Diabetes Drugs Product and Services
Table 50. Hua Dong Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 52. Huadong Medicine Major Business
Table 53. Huadong Medicine Diabetes Drugs Product and Services
Table 54. Huadong Medicine Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Jumpcan Pharmacy Basic Information, Manufacturing Base and Competitors
Table 56. Jumpcan Pharmacy Major Business
Table 57. Jumpcan Pharmacy Diabetes Drugs Product and Services
Table 58. Jumpcan Pharmacy Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. KELUN Basic Information, Manufacturing Base and Competitors
Table 60. KELUN Major Business
Table 61. KELUN Diabetes Drugs Product and Services
Table 62. KELUN Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 64. Merck & Co. Major Business
Table 65. Merck & Co. Diabetes Drugs Product and Services
Table 66. Merck & Co. Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. MSD Basic Information, Manufacturing Base and Competitors
Table 68. MSD Major Business
Table 69. MSD Diabetes Drugs Product and Services
Table 70. MSD Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. North China Pharmaceutical Group Corporation Basic Information, Manufacturing Base and Competitors
Table 72. North China Pharmaceutical Group Corporation Major Business
Table 73. North China Pharmaceutical Group Corporation Diabetes Drugs Product and Services
Table 74. North China Pharmaceutical Group Corporation Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Novartis Basic Information, Manufacturing Base and Competitors
Table 76. Novartis Major Business
Table 77. Novartis Diabetes Drugs Product and Services
Table 78. Novartis Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 80. Novo Nordisk Major Business
Table 81. Novo Nordisk Diabetes Drugs Product and Services
Table 82. Novo Nordisk Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Sanofi Basic Information, Manufacturing Base and Competitors
Table 84. Sanofi Major Business
Table 85. Sanofi Diabetes Drugs Product and Services
Table 86. Sanofi Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. SHIJIAZHUANG YILING PHARMACEUTICAL Basic Information, Manufacturing Base and Competitors
Table 88. SHIJIAZHUANG YILING PHARMACEUTICAL Major Business
Table 89. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Product and Services
Table 90. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Takeda Basic Information, Manufacturing Base and Competitors
Table 92. Takeda Major Business
Table 93. Takeda Diabetes Drugs Product and Services
Table 94. Takeda Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. Taloph Basic Information, Manufacturing Base and Competitors
Table 96. Taloph Major Business
Table 97. Taloph Diabetes Drugs Product and Services
Table 98. Taloph Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. Tianan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 100. Tianan Pharmaceutical Major Business
Table 101. Tianan Pharmaceutical Diabetes Drugs Product and Services
Table 102. Tianan Pharmaceutical Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. Tonghua DongBao Basic Information, Manufacturing Base and Competitors
Table 104. Tonghua DongBao Major Business
Table 105. Tonghua DongBao Diabetes Drugs Product and Services
Table 106. Tonghua DongBao Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 107. Wanbang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 108. Wanbang Biopharmaceuticals Major Business
Table 109. Wanbang Biopharmaceuticals Diabetes Drugs Product and Services
Table 110. Wanbang Biopharmaceuticals Diabetes Drugs Sales (M Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 111. Global Diabetes Drugs Sales by Manufacturer (2019-2021e) & (M Units)
Table 112. Global Diabetes Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 113. Market Position of Manufacturers in Diabetes Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 114. Global Diabetes Drugs Production Capacity by Company, (M Units): 2020 VS 2021
Table 115. Head Office and Diabetes Drugs Production Site of Key Manufacturer
Table 116. Diabetes Drugs New Entrant and Capacity Expansion Plans
Table 117. Diabetes Drugs Mergers & Acquisitions in the Past Five Years
Table 118. Global Diabetes Drugs Sales by Region (2016-2021e) & (M Units)
Table 119. Global Diabetes Drugs Sales by Region (2021-2026) & (M Units)
Table 120. Global Diabetes Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 121. Global Diabetes Drugs Revenue by Region (2021-2026) & (USD Million)
Table 122. Global Diabetes Drugs Sales by Type (2016-2021e) & (M Units)
Table 123. Global Diabetes Drugs Sales by Type (2021-2026) & (M Units)
Table 124. Global Diabetes Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 125. Global Diabetes Drugs Revenue by Type (2021-2026) & (USD Million)
Table 126. Global Diabetes Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 127. Global Diabetes Drugs Price by Type (2021-2026) & (USD/Unit)
Table 128. Global Diabetes Drugs Sales by Application (2016-2021e) & (M Units)
Table 129. Global Diabetes Drugs Sales by Application (2021-2026) & (M Units)
Table 130. Global Diabetes Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 131. Global Diabetes Drugs Revenue by Application (2021-2026) & (USD Million)
Table 132. Global Diabetes Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 133. Global Diabetes Drugs Price by Application (2021-2026) & (USD/Unit)
Table 134. North America Diabetes Drugs Sales by Country (2016-2021e) & (M Units)
Table 135. North America Diabetes Drugs Sales by Country (2021-2026) & (M Units)
Table 136. North America Diabetes Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 137. North America Diabetes Drugs Revenue by Country (2021-2026) & (USD Million)
Table 138. North America Diabetes Drugs Sales by Type (2016-2021e) & (M Units)
Table 139. North America Diabetes Drugs Sales by Type (2021-2026) & (M Units)
Table 140. North America Diabetes Drugs Sales by Application (2016-2021e) & (M Units)
Table 141. North America Diabetes Drugs Sales by Application (2021-2026) & (M Units)
Table 142. Europe Diabetes Drugs Sales by Country (2016-2021e) & (M Units)
Table 143. Europe Diabetes Drugs Sales by Country (2021-2026) & (M Units)
Table 144. Europe Diabetes Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 145. Europe Diabetes Drugs Revenue by Country (2021-2026) & (USD Million)
Table 146. Europe Diabetes Drugs Sales by Type (2016-2021e) & (M Units)
Table 147. Europe Diabetes Drugs Sales by Type (2021-2026) & (M Units)
Table 148. Europe Diabetes Drugs Sales by Application (2016-2021e) & (M Units)
Table 149. Europe Diabetes Drugs Sales by Application (2021-2026) & (M Units)
Table 150. Asia-Pacific Diabetes Drugs Sales by Region (2016-2021e) & (M Units)
Table 151. Asia-Pacific Diabetes Drugs Sales by Region (2021-2026) & (M Units)
Table 152. Asia-Pacific Diabetes Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 153. Asia-Pacific Diabetes Drugs Revenue by Region (2021-2026) & (USD Million)
Table 154. Asia-Pacific Diabetes Drugs Sales by Type (2016-2021e) & (M Units)
Table 155. Asia-Pacific Diabetes Drugs Sales by Type (2021-2026) & (M Units)
Table 156. Asia-Pacific Diabetes Drugs Sales by Application (2016-2021e) & (M Units)
Table 157. Asia-Pacific Diabetes Drugs Sales by Application (2021-2026) & (M Units)
Table 158. South America Diabetes Drugs Sales by Country (2016-2021e) & (M Units)
Table 159. South America Diabetes Drugs Sales by Country (2021-2026) & (M Units)
Table 160. South America Diabetes Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 161. South America Diabetes Drugs Revenue by Country (2021-2026) & (USD Million)
Table 162. South America Diabetes Drugs Sales by Type (2016-2021e) & (M Units)
Table 163. South America Diabetes Drugs Sales by Type (2021-2026) & (M Units)
Table 164. South America Diabetes Drugs Sales by Application (2016-2021e) & (M Units)
Table 165. South America Diabetes Drugs Sales by Application (2021-2026) & (M Units)
Table 166. Middle East & Africa Diabetes Drugs Sales by Country (2016-2021e) & (M Units)
Table 167. Middle East & Africa Diabetes Drugs Sales by Country (2021-2026) & (M Units)
Table 168. Middle East & Africa Diabetes Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 169. Middle East & Africa Diabetes Drugs Revenue by Country (2021-2026) & (USD Million)
Table 170. Middle East & Africa Diabetes Drugs Sales by Type (2016-2021e) & (M Units)
Table 171. Middle East & Africa Diabetes Drugs Sales by Type (2021-2026) & (M Units)
Table 172. Middle East & Africa Diabetes Drugs Sales by Application (2016-2021e) & (M Units)
Table 173. Middle East & Africa Diabetes Drugs Sales by Application (2021-2026) & (M Units)
Table 174. Direct Channel Pros & Cons
Table 175. Indirect Channel Pros & Cons
Table 176. Diabetes Drugs Typical Distributors
Table 177. Diabetes Drugs Typical Customers
List of Figures
Figure 1. Diabetes Drugs Picture
Figure 2. Global Diabetes Drugs Sales Market Share by Type in 2020
Figure 3. Insulin
Figure 4. DPP-4
Figure 5. GLP-1
Figure 6. SGLT-2
Figure 7. Global Diabetes Drugs Sales Market Share by Application in 2020
Figure 8. Type 1 Diabetes
Figure 9. Type 2 Diabetes
Figure 10. Global Diabetes Drugs Market Size, (USD Million) & (M Units): 2020 VS 2021 VS 2026
Figure 11. Global Diabetes Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Diabetes Drugs Sales (2016-2026) & (M Units)
Figure 13. Global Diabetes Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 14. Global Diabetes Drugs Production Capacity (2016-2026) & (M Units)
Figure 15. Global Diabetes Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Diabetes Drugs Market Drivers
Figure 17. Diabetes Drugs Market Restraints
Figure 18. Diabetes Drugs Market Trends
Figure 19. Global Diabetes Drugs Sales Market Share by Manufacturer in 2020
Figure 20. Global Diabetes Drugs Revenue Market Share by Manufacturer in 2020
Figure 21. Diabetes Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Diabetes Drugs Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Diabetes Drugs Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Diabetes Drugs Sales Market Share by Region (2016-2026)
Figure 25. Global Diabetes Drugs Revenue Market Share by Region (2016-2026)
Figure 26. North America Diabetes Drugs Revenue (2016-2026) & (USD Million)
Figure 27. Europe Diabetes Drugs Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Diabetes Drugs Revenue (2016-2026) & (USD Million)
Figure 29. South America Diabetes Drugs Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Diabetes Drugs Revenue (2016-2026) & (USD Million)
Figure 31. Global Diabetes Drugs Sales Market Share by Type (2016-2026)
Figure 32. Global Diabetes Drugs Revenue Market Share by Type (2016-2026)
Figure 33. Global Diabetes Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 34. Global Diabetes Drugs Sales Market Share by Application (2016-2026)
Figure 35. Global Diabetes Drugs Revenue Market Share by Application (2016-2026)
Figure 36. Global Diabetes Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 37. North America Diabetes Drugs Sales Market Share by Type (2016-2026)
Figure 38. North America Diabetes Drugs Sales Market Share by Application (2016-2026)
Figure 39. North America Diabetes Drugs Sales Market Share by Country (2016-2026)
Figure 40. North America Diabetes Drugs Revenue Market Share by Country (2016-2026)
Figure 41. United States Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Diabetes Drugs Sales Market Share by Type (2016-2026)
Figure 45. Europe Diabetes Drugs Sales Market Share by Application (2016-2026)
Figure 46. Europe Diabetes Drugs Sales Market Share by Country (2016-2026)
Figure 47. Europe Diabetes Drugs Revenue Market Share by Country (2016-2026)
Figure 48. Germany Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Diabetes Drugs Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Diabetes Drugs Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Diabetes Drugs Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Diabetes Drugs Revenue Market Share by Region (2016-2026)
Figure 57. China Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Diabetes Drugs Sales Market Share by Type (2016-2026)
Figure 64. South America Diabetes Drugs Sales Market Share by Application (2016-2026)
Figure 65. South America Diabetes Drugs Sales Market Share by Country (2016-2026)
Figure 66. South America Diabetes Drugs Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Diabetes Drugs Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Diabetes Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Diabetes Drugs Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Diabetes Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source

---